Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Rapid Micro Biosystems, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $74.70M | $73.23M - $75.97M | -$74.70M | -$0.47 | 1 |
| Dec 2028 | $65.00M | $63.73M - $66.10M | -$65.00M | -$0.47 | 1 |
| Dec 2027 | $46.58M | $45.66M - $47.37M | -$46.58M | -$0.79 | 3 |
| Dec 2026 | $39.30M | $38.53M - $39.97M | -$39.30M | -$0.93 | 3 |
| Dec 2025 | $33.65M | $32.99M - $34.22M | -$33.65M | -$1.007 | 1 |
| Dec 2024 | $27.67M | $27.12M - $28.14M | -$27.67M | -$1.083 | 1 |
| Dec 2023 | $23.09M | $22.67M - $23.50M | -$23.09M | -$1.203 | 1 |
| Dec 2022 | $17.33M | $17.19M - $17.62M | -$17.33M | -$1.413 | 1 |
| Dec 2021 | $23.66M | $23.46M - $24.05M | -$23.66M | -$2.38 | 1 |